AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

NYU Langone’s decision comes amid Trump administration threats to cut funding to providers who treat trans youth NYU Langone Health, one of New York City’s major hospital networks, announced this week ...

The NASA Mars Sample Return program is encountering resistance from the planetary science community due to proposed budget language that would terminate the current mission framework. In early January ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Luxury EVs in China now offer 24-karat gold badges and Porsche-like options — but at half the price. Porsche faces a myriad of problems in China. For one, the brand’s cars are somewhat niche by design ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with ...

Rachel Ho is a rising 10th-grader at Langley High School in McLean. She loves writing and thinks she might want to follow in her mother’s footsteps and study at the University of Virginia. To get a ...

A minor proprietor will observe customers who hyped about their product. They are interested in transforming this excitement into expansion. Exit, such as referral programs, e.g., the idea to give 10 ...